Stay in the know
Receive timely insights and briefings from HSF Kramer, tailored to keep you informed and ahead
Subscribe now
Herbert Smith Freehills Kramer (HSF Kramer) is pleased to be advising CSL on its recently announced proposed demerger of its Seqirus business (Seqirus) as a standalone ASX-listed entity by the end of Financial Year 2026.
Seqirus is one of the world’s largest influenza vaccine providers, dedicated to advancing public health through innovative vaccine solutions and pandemic preparedness.
The HSF Kramer team is led by partners Priscilla Bryans, Baden Furphy, Alexander Mackinnon, and Michael Ziegelaar, with partner Ryan Leslie advising on the tax aspects of the transaction.
Key contacts
Priscilla Bryans
Partner, Melbourne
Baden Furphy
Partner, Melbourne
Alexander Mackinnon
Partner, Melbourne
Michael Ziegelaar
Partner, Melbourne
Ryan Leslie
Partner, Melbourne
Media contact
For further information on this news article, please contact:
Gina Baldassarre
External Communications Manager
Sydney
More news
24 八月 2026
Herbert Smith Freehills Kramer advises Malibu Life Holdings Limited on landmark capital raise - the first fully pre-emptive Main Market capital raise to take advantage of the new UK Prospectus Regime
Leading global law firm Herbert Smith Freehills Kramer has advised long-standing London-listed client Malibu Life Holdings Limited (Malibu Life) on its …
18 八月 2026
HSF Kramer and Melbourne Business School launch enterprise bargaining negotiation program
Leading global law firm Herbert Smith Freehills Kramer (HSF Kramer) has partnered with Melbourne Business School to launch its inaugural industrial …
18 八月 2026
Herbert Smith Freehills Kramer advises sponsors on the Jaalan Bani Bu Ali Wind Independent Power Project in Oman
Leading global law firm Herbert Smith Freehills Kramer has advised the sponsors on the development and financing aspects of the 120 MW Jaalan Bani Bu Ali …